HU7-11098-13966
4 vaccinations
6 coded responses
32 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 481 / MI
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-27
- 2021-01-01
-
2021-01-05
Dose 2 — Pfizer-BioNTech
-
2021-01-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-09
-
2021-01-14
Survey response — day 7, dose 2MedDRA: Hospitalisation, Pre-eclampsia — Feeling: Good · Get care from a doctor or other healthcare professional · HospitalizationFree text: Systemic reaction (other): Pre-Eclampsia · Healthcare visit (other): Was admitted for pre-eclampsiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Report sent to call center — day 7, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-19
- 2021-01-26
- 2021-02-02
- 2021-02-06
-
2021-02-09
Survey response — day 35, dose 2MedDRA: Caesarean section, Obstetric procedure complication — Feeling: Fair · Get care from a doctor or other healthcare professional · HospitalizationFree text: C-section and complicationsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-09
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-16
- 2021-02-26
- 2021-04-06
- 2021-07-06
-
2021-10-19
Dose 3 — Pfizer-BioNTech
- 2022-01-05
-
2022-09-16
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-20
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-10-02
-
2022-10-07
Survey response — day 21, dose 4MedDRA: Headache — Feeling: GoodFree text: HeadacheMedDRA releases: 2024-11 · check-in free text available
-
2022-10-16
Survey response — day 28, dose 4MedDRA: Nasopharyngitis — Feeling: GoodFree text: Cold like symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-10-21
- 2022-10-30
-
2022-12-16
Survey response — 3 months, dose 4MedDRA: Influenza — Feeling: Poor · Be unable to do your normal daily activitiesFree text: FluMedDRA releases: 2024-11 · check-in free text available
-
2023-03-19
Survey response — 6 months, dose 4MedDRA: Upper respiratory tract infection — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech | |
| 3 | 2021-10-19 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Pfizer-BioNTech | Flu |
Call center
2 call center cases
2 unsuccessful
Free text
Release 1 — day 7, dose 2
Systemic reaction (other): Pre-Eclampsia
Healthcare visit (other): Was admitted for pre-eclampsia
Release 3 — day 35, dose 2
Symptoms: C-section and complications
Release 12 — day 21, dose 4
Symptoms: Headache
Release 12 — day 28, dose 4
Symptoms: Cold like symptoms
Release 12 — 3 months, dose 4
Symptoms: Flu
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Hospitalisation | ✓ | ✓ | ✓ |
| HCVO | Pre-eclampsia | ✓ | ✓ | ✓ |
| SD | Caesarean section | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Obstetric procedure complication | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Pre-eclampsia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release